Long-term results of intrapericardial chemotherapeutic treatment of malignant pericardial effusions with thiotepa

Chest

Volumn 126, Issue 5, 2004, Pages 1412-1416

  Martinoni, Alessandro ^a,b   Cipolla, Carlo Maria ^a   Cardinale, Daniela ^a   Civelli, Maurizio ^a   Lamantia, Giuseppina ^a   Colleoni, Marco ^a   Fiorentini, Cesare ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Invasive Cardiology Unit   (Italy)

Author keywords

Antineoplastic agents; Cardiac tamponade; Neoplasms; Pericardial effusion; Thiotepa

Indexed keywords

HYDROCORTISONE; THIOTEPA;

ALKYLATION; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER GROWTH; CATHETERIZATION; CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG INSTILLATION; ECG ABNORMALITY; ECHOCARDIOGRAPHY; ENDOMETRIUM CANCER; FEMALE; HEART TAMPONADE; HUMAN; HUMAN CELL; ISCHEMIA; KAPLAN MEIER METHOD; LONG TERM CARE; LUNG NON SMALL CELL CANCER; MALE; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; PERCUTANEOUS CORONARY INTERVENTION; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDIUM; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENT DISEASE; SCLEROTHERAPY; SIDE EFFECT; SURGICAL DRAINAGE; SURVIVAL RATE; SURVIVAL TIME; THORAX PAIN; TUMOR CELL;

EID: 8744258854     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.126.5.1412     Document Type: Article

References (27)

1. Soler-Soler J, Sagristà-Sauleda J, Permanyer-Miralda G. Management of pericardial effusions. Heart 2001; 86:235-240
2. Girardi LN, Ginsberg RJ, Burt ME. Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg 1997; 64:1422-1428
3. Wall TC, Campbell PT, O'Connor CM, et al. Diagnosis and management (by subxiphoid pericardiotomy) of large pericardial effusions causing cardiac tamponade. Am J Cardiol 1992; 69:1075-1078
4. Moores DW, Allen KB, Faber LP, et al. Subxiphoid pericardial drainage for pericardial tamponade. J Thorac Cardiovasc Surg 1995; 109:546-551
5. Okamoto H, Shinkai T, Yamakido M, et al. Cardiac tamponade caused by primary lung cancer and the management of pericardial effusion. Cancer 1993; 71:93-98
6. Tsang TS, Freeman WK, Sinak LJ, et al. Echocardiographically guided pericardiocentesis: evolution and state-of-the-art technique. Mayo Clin Proc 1998; 73:647-652
7. Wilkes JD, Fidias P, Vaickus L, et al. Malignancy-related pericardial effusion. Cancer 1995; 76:1377-1387
8. Klatt EC, Heitz DR. Cardiac metastasis. Cancer 1990; 65: 1456-1459
9. Thurber DL, Edwards JE, Achor RW. Secondary malignant tumors of the pericardium. Circulation 1962; 26:228-241
10. Bisel HF, Wroblewski F, LaDue JS. Incidence and clinical manifestations of cardiac metastases. JAMA 1953; 153:712-715
11. Hawkins JW, Vacek JL. What constitutes definitive therapy of malignant pericardial effusion? "Medical" versus surgical treatment. Am Heart J 1989; 118:428-432
12. Tamura A, Matsubara O, Yoshimura N, et al. Cardiac metastases of lung cancer. Cancer 1992; 70:437-442
13. Shepherd FA, Morgan C, Evans WK, et al. Medical management of malignant pericardial effusion by tetracycline sclerosis. Am J Cardiol 1987; 60:1161-1166
14. Davis S, Sharma SM, Blumberg ED, et al. Intrapericardial tetracycline for the management of cardiac tamponade secondary to malignant pericardial effusion. N Engl J Med 1978; 299:1113-1114
15. Treatment of malignant pleural and pericardial effusion. Med Lett Drugs Ther 1981; 23:57-60
16. Lashevsky I, Yosef RB, Rinkevich D, et al. Intrapericardial minocycline sclerosis for malignant pericardial effusion. Chest 1996; 109:1452-1454
17. Dryzer SR, Joseph J, Baumann M, et al. Early inflammatory response of minocycline and tetracycline and tetracycline on the rabbit pleura. Chest 1993; 104:1585-1588
18. Light RW, Wang NS, Sassoon CS. Comparison of the effectiveness of tetracycline and minocycline as pleural sclerosing agents in rabbits. Chest 1994; 106:577-582
19. Liu G, Crump M, Goss PE, et al. Prospective comparison of the sclerosing agents doxycycline and bleomycin for the primary management of malignant pericardial effusion and cardiac tamponade. J Clin Oncol 1996; 14:3141-3147
20. Vaitkus PT, Herrmann HC, LeWinter MM. Treatment of malignant pericardial effusion. JAMA 1994; 272:59-64
21. Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987; 257:1088-1092
22. Sharma A, Kamble R, Kumar L, et al. Palliative treatment of malignant pericardial effusion: report of two cases and a review of the literature. Support Care Cancer 1996; 4:317-319
23. Maher EA, Shepherd FA, Todd TJ. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996; 112:637-643
24. Koontz WW, Prout GR, Smith W, et al. The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladder. J Urol 1981; 125:307-312
25. De Kock MLS, Breytenbach IH. Local excision and topical thiotepa in the treatment of transitional cell carcinoma of the renal perlvis: a case report. J Urol 1986; 135:566-567
26. Bishiniotis TS, Antoniadou S, Katseas G, et al. Malignant cardiac tamponade in women with breast cancer treated by pericardiocentesis and intrapericardial administration of triethylenethiophosphoramide (thiotepa). Am J Cardiol 2000; 86:362-364
27. Martinoni A, Cipolla CM, Civelli M, et al. Intrapericardial treatment of neoplastic pericardial effusions. Herz 2000; 25:787-793